A number of nicotinic acetycholine receptors (nAChR) are being actively used as ion channel drug targets. These measurements pose unique challenges for automated patch clamp instrumentation. This is due to the fast kinetics of a number of nAChR ion channel types, as well as the need to limit the agonist exposure time across a large number of parallel recordings in order to control desensitization. In this study we present data relating to the fast recovery from desensitization that, for a next generation automated patch clamp platform, is mediated by continuous flow and microfluidic compound delivery. EC50 data for known agonists will be presented, along with reference compound data. 
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The Binding Site for 17b-Estradiol Can be Placed on Any Subunit of a Nicotinic a4b2 Receptor Xiaochun Jin, Joe Henry Steinbach. Endogenous steroids can modulate the activity of transmitter-gated channels by directly interacting with the receptor. 17b-Estradiol potentiates activation of neuronal nicotinic a4b2 receptors by interacting with a 4 amino-acid sequence at the extreme carboxy-terminus of the a4 subunit. Nicotinic receptors are pentamers of related subunits, and contain 2 binding sites for acetylcholine at interfaces between an a4 and a b2 subunit. It is not known whether potentiation requires that the sequence be placed on a specific subunit (e.g. an a4 subunit which is involved in forming an acetylcholine-binding site). By using concatemers of subunits and chimeric subunits, we have found that the recognition sequence can be moved from the a4 to the b2 subunit and still result in equivalent potentiation. The sequence also can be placed on an acetylcholine-binding subunit or on the 5th (structural) subunit. The amount of potentiation increases with increasing numbers of copies of the binding site in the assembled pentamer. The data indicate that the estradiol-binding sequence is a discrete element, and suggest that the effect of 17b-estradiol is mediated by actions on single subunits and that the overall consequences for gating occur due to the summation of independent energetic contributions to overall gating of this receptor. Supported by NIH NS22356 & GM47969.
1494-Pos Board B404
Interaction of Tricyclic Antidepressants with the Ha3b4 Nicotinic Receptor Dominic Williams, Ali H. Ahmad, Katarzyna M. Targowska-Duda, Dominik Feuerbach, Krzysztof Jozwiak, Hugo R. Arias. The interaction of tricyclic antidepressants (TCAs) with human (h)a3b4 nicotinic acetylcholine receptor (AChR) was compared to that for mecamylamine.
The results established that: (a) [3H]imipramine binds to a single site with high affinity (Kd = 0.41 5 0.04 mM), (b) imipramine inhibits [3H]imipramine binding to resting AChR with the same affinity as to desensitized AChR, suggesting that TCAs do not distinguish between these conformational states, (c) imipramine inhibits [3H]ibogaine binding, suggesting mutual interaction between both compounds, (d) both TCAs and mecamylamine inhibit (5)-epibatidineinduced Ca2þ influx with potencies in the same concentration range, but only TCAs inhibit [3H]imipramine binding to ha3b4 AChRs. This is supported by our molecular docking results, where imipramine, in the neutral and protonated states, interacts with the leucine (position 9') and valine/phenylalanine (position 13') rings, while protonated mecamylamine interacts with the outer ring (position 20'). Our data suggest that TCAs and ibogaine bind to overlapping sites located between the serine and valine/phenylalanine rings in the ha3b4 AChR ion channel, while protonated mecamylamine can be attracted to the channel mouth before blocking ion flux by interacting with a luminal site in its neutral state.
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Estimating Agonist Efficacy by Engineering Acetylcholine Receptor-Channels Snehal V. Jadey, Prasad Purohit, Iva Bruhova, Timothy Gregg, Anthony Auerbach. Nicotinic acetylcholine receptor-channels (AChRs) are allosteric proteins that spontaneously isomerize ('gate') between a resting, closed-channel conformation (R) and an active, open-channel one (R*). Different agonists promote the R-R* conformational change to different extents because they experience different degrees of affinity change at the agonist binding site. The affinity ratio, R/R*, is the parameter that determines the gating equilibrium constant E 2 and, hence, efficacy. The most accurate way to estimate E 2 is by using single-channel, patch-clamp electrophysiology. However, we wanted to examine ligand/receptor combinations that have gating rate constants either too-fast or too-slow for such analysis. In this study we describe and use a stepwise perturbation method involving mutations, depolarization and partial agonists to circumvent problems associated with the bandwidth limitations of patch electrophysiology and channel block by agonist molecules, in order to determine accurately rate constants at single channel level of seven agonists with varying efficacies. Our estimates for known agonists, obtained by using this method are in excellent agreement with previously published values. This shows that the effects on gating from the perturbations we employed are the same regardless of the activating agonist and, conversely, the effects of the agonist are independent of the perturbations. The 'improved' gating constant estimates for ACh on wild type, adult mouse neuromuscular AChRs (À100 mV, 23 o C, expressed in HEK cells) are: opening rate: 66,000 s À1 , closing rate: 2300 s
À1
, and equilibrium: 29.
1496-Pos Board B406 Molecular Thermography: Mapping Enthalpy and Entropy Changes in Acetylcholine Receptor Gating Shaweta Gupta, Anthony Auerbach. We studied enthalpy and entropy changes in AChR gating from the temperature dependence of the gating rate and equilibrium constants estimated from the single-channel currents from wild type and mutant AChRs activated by different agonists (acetylcholine , choline, carbachol or none) (5-35oC, HEK cells, cell attached , À110 mV , mouse a[[Unsupported Character -]]bde). The mutations were between the binding sites and the gate, in the a-subunit [W149, G153, A96, Y127, E45, P272, P265 and C418] or the dsubunit [V269 and L265]. The forward and reverse isomerization rate constants were temperature-dependent (activation enthalpy~21 kcal/mol; Q10~3.8). For aG153S, aW149T, aP272G and three different agonists the free energy change (aaGo, at 25oC) and the enthalpy change (aaHo) were approximately equal. These values differed by >2 kcal/mol for aY127C/E, aW149F/N/R and dV269C/A. The slope of the rate-equilibrium free energy relationship (F) for residues aW149 and dV269 was constant with temperature, and the slope for the enthalpy component of this relationship was equal to F. The results suggest that the map of gating enthalpy changes consequent to mutation are different than that for free energy changes. We speculate that the changes in enthalpy are mainly local to the site of perturbation and that we can make a residue-by-residue map of heat absorption and emission in AChR gating (a 'molecular thermogram').
274a Monday, March 7, 2011 
